Dr. Liu is a board-certified PhD clinical geneticist with a primary research interest in translating new technologies into clinical testing to advance the diagnostics and therapy of rare diseases. His clinical work has provided key evidence to recognize the necessity and importance of clinical reanalysis of diagnostic exome data. Dr. Liu has spearheaded the implementation of clinical whole-genome sequencing and clinical RNA sequencing for the Undiagnosed Diseases Network (UDN) and has launched these clinical tests at the Baylor Genetics diagnostic laboratory. He has received multiple honors and awards, including the Michael Watson's Genome Medicine Innovation Award from the ACMG, the Genomic Innovator Award from the NHGRI, and the Cotterman Award from the ASHG.